Skip to main content
. 2020 Aug 21;16:769–785. doi: 10.2147/TCRM.S207117

Table 2.

Step 2 (E): Echocardiographic and Natriuretic Peptide Heart Failure with Preserved Ejection Fraction Workup and Scoring System (Diagnostic Workup)

Functional Morphological Biomarker (Sinus Rhythm) Biomarker (Atrial Fibrillation)
septal e´ < 7 cm/s or lateral e´ < 10 cm/s
or
average E/e´ ≥ 15
or
TR velocity > 2.8 m/s (PASP > 35 mm Hg)
LAVI > 34 mL/m2
or
LVMI ≥ 149/122g/m2 (m/w)
and RWT>0,42
NT-pro BNP > 220 pg/mL
or
BNP > 80 pg/mL
NT-pro BNP > 660 pg/mL
or
BNP > 240 pg/mL
Average E/e´ 9–14
or
GLS < 16%
LAVI 29–34 mL/m2
or
LVMI > 115/95g/m2 (m/w) or
RWT>0,42
or
LV wall thickness ≥ 12 mm
NT-pro BNP 125–220 pg/mL
or
BNP 35–80 pg/mL
NT-pro BNP 365–660 pg/mL
or
BNP 105–240 pg/mL

Note: Data from Pieske et al.5